哈米因通过ROS/p38轴发挥抗癌作用,在骨髓瘤中诱导自和亡
1Department of Orthopedic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Bioorganic chemistry
|May 9, 2025
概括
植物类化合物哈米因通过增加活性氧物种 (ROS) 和激活p38信号,从而抑制骨髓瘤生长,导致细胞死亡,并在临床前模型中减少瘤进展.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 骨髓瘤是一种侵袭性骨癌,主要影响青少年,往往导致转移和死亡.
- 哈米因是一种来自植物的β-卡博林类化合物,具有已知的抗炎和抗瘤特性.
- 哈米因在骨髓瘤治疗中的治疗潜力以前没有被研究过.
研究的目的:
- 为了研究哈尔因作为一种潜在的治疗药物对抗骨髓瘤的疗效.
- 阐明哈米因影响骨髓瘤细胞的潜在分子机制.
主要方法:
- 在体外研究评估哈米因对骨髓瘤细胞增殖,入侵和迁移的影响.
- 对细胞内活性氧物种 (ROS) 水平,p38酸化,自和亡标记物的分析.
- 在体内外移植的小鼠模型来评估瘤生长抑制和安全性.
主要成果:
- 哈米因证明了依赖于剂量和时间的抑制骨髓瘤细胞生长,入侵和迁移.
- 哈米因治疗增加了细胞内ROS,诱导了p38酸化,并触发了自和亡.
- ROS捕食者和p38抑制剂减弱了哈米因诱导的自和亡.
- 在体内,Harmine显著减少了瘤体积和体重,而不会引起主要的器官毒性.
- 瘤组织显示了下调的PCNA和上调的割裂caspase-3,LC3BII/I,以及化p38.
结论:
- 在临床前的环境中,哈米因对骨髓瘤表现出显著的抗瘤活性.
- 该机制涉及ROS生成和p38通路激活,导致自和亡.
- 哈尔是骨髓瘤治疗的有希望的治疗候选者,具有良好的安全性.
更多相关视频
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
1.4K
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.7K
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
